Next Article in Journal
Culinary Preparation and Consumption Habits of Osbana: An Algerian Cooked Sausage-like Traditional Meat Product
Previous Article in Journal
The Antioxidant Power of an Algerian Dry Date Variety Phoenix dactylifera L.
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Proceeding Paper

The Role of Plant-Derived Prebiotics in Obesity Management: Mechanisms, Efficacy, and Active Compounds †

by
Ilyes Ghodbane
1,*,
Said Boukhechem
1,
Hithem Bougherara
1,
Magali Monnoye
2,
Ibtissem Oubira
1,
Nedjoua Lakhdara
1,
Philippe Gerard
2 and
Amira Leila Dib
1
1
Gestion de la Santé et Productions Animales Research Laboratory, Institut des Sciences Vétérinaires El-Khroub, Univesité de Constantine 1-Frères Mentouri, Constantine 25017, Algeria
2
Institut Micalis, INRAE, AgroParisTech, Université Paris-Saclay, 78350 Jouy-en-Josas, France
*
Author to whom correspondence should be addressed.
Presented at the 11th International Seminar of Veterinary Medicine: Advances in Animal Production, Food, and Health: From Tradition to Innovation, Constantine, Algeria, 26–27 October 2024.
Biol. Life Sci. Forum 2025, 49(1), 13; https://doi.org/10.3390/blsf2025049013
Published: 25 September 2025

Abstract

Obesity, a multicausal global health disorder, requires innovative solutions beyond conventional weight control. Plant-derived prebiotics, like inulin, oligofructose, and resistant dextrin, have appeared as promising dietary interventions. These fibers nourish beneficial gut bacteria, which produce short-chain fatty acids (SCFAs) that regulate appetite, enhance fat combustion, and improve metabolic markers. Clinical trials show that the consumption of 8–21 g/day prebiotics for 8–24 weeks reduces body weight, BMI, waist circumference, inflammation, and insulin resistance. By exploring mechanisms, bioactive molecules, and personalized approaches, this review highlights prebiotics’ potential as natural anti-obesity agents. However, further research is needed to optimize their contribution to public health initiatives for the effective management of obesity.

1. Introduction

Obesity is a global pandemic disease with severe health implications like heart disease, diabetes, and cancer [WHO]. Since conventional weight-loss diets are not successful in the long term, prebiotics, i.e., non-digestible plant fiber present in food items like chicory root and corn, are an option. Prebiotics serve as food for good gut bacteria, enhancing SCFA [1,2,3] production, which regulates appetite, metabolism, and inflammation. Clinical trials confirm that prebiotics reduce body weight, body mass index, and waist circumference and improve insulin sensitivity [4,5,6]. Their active components, best doses (8–21 g/day), and durations of treatment are outlined herein in review to make prebiotics evidence-based anti-obesity and obesity complication weapons.

2. Materials and Methods

A systematic review of clinical studies that assessed the effect of prebiotics on obesity was conducted. The keywords used in the search were “prebiotics,” “obesity,” “gut microbiota,” “Oligofructose”, and “inulin.” Data were collected from studies published from 2009 to 2023. Articles that were selected focused on trials with human subjects using prebiotics derived from plant sources like chicory root, corn, and rice bran

3. Results and Discussion

Clinical trials in Table 1 demonstrate that plant-derived prebiotics (e.g., chicory root, corn) combat obesity by modulating gut microbiota. These fibers—particularly inulin, oligofructose (8–16 g/day for 12–16 weeks) [1,7,8] and resistant dextrin (10–20 g/day for 12 weeks) [2]—stimulate Bifidobacteria and Lactobacilli, leading to increased short-chain fatty acid (SCFA) production. SCFAs improve metabolic parameters like insulin sensitivity while reducing fat storage and appetite control [1,2]. However, effectiveness is source-specific; for instance, lyophilized juçara showed no effect [4], indicating the importance of prebiotic subtype and personal metabolic response in the treatment of obesity protocols.

3.1. Study Design and Control Measures

The trials, being randomized placebo-controlled trials, also controlled for the effects of diet and exercise so that the findings of weight loss were due to prebiotics. Even in trials with a hypocaloric diet or exercise, the effect ofprebiotics alone was isolated.

3.2. Physiological Factors and Participant Demographics

In the case of ethnic and physiological status, both women and men, children and adults, all of whom were obese or overweight, were covered in the studies, depicting the effect of prebiotics in different physiological conditions.

3.3. Ethnic Considerations and Population Relevance

Ethnically, most of the trials were conducted on Persians (Iranians), North Americans (Canadians), and Northern Europeans (The Netherlands and Belgium), showing the feasibility of using prebiotics in various populations.

3.4. Prebiotics and Their Role in Weight Loss

Prebiotics are shown to cause weight loss independent of caloric restriction as shown in Table 1 by modulating gut microbiota, regulating appetite, and boosting metabolism. Its effect can be optimized if combined with a healthy lifestyle.

4. Conclusions

These findings highlight the potential of plant-derived prebiotics as natural interventions for obesity management, with active compounds, appropriate dosages, and durations playing key roles in their effectiveness. Future research is needed to further elucidate the mechanisms of action, optimize dosages, and explore the synergistic effects of prebiotics when combined with probiotics as synbiotics.

Author Contributions

Conceptualization, I.G. and A.L.D.; methodology, I.G., A.L.D., P.G., and H.B.; software, S.B., M.M. and H.B.; validation, A.L.D., P.G.; formal analysis, S.B.; investigation, I.G. and A.L.D.; data curation, I.G., A.L.D. and P.G. writing—original draft preparation, I.G.; writing—review and editing, I.G.; visualization, A.L.D., P.G., I.O., N.L. and P.G.; supervision, A.L.D.; project administration, A.L.D. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available upon request from the corresponding author.

Acknowledgments

This work is a part of the project agreement number D04N02UN250120230002. The authors acknowledge the support and help of El-Hacene Bererhi, the Director of Veterinary Institute Sciences, El-Khroub, Algeria; Mohammed Gagaoua, a researcher from PEGASE INRAE, France.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Nicolucci, A.C.; Hume, M.P.; Martínez, I.; Mayengbam, S.; Walter, J.; Reimer, R.A. Prebiotics reduce body fat and alter intestinal microbiota in children who are overweight or with obesity. Gastroenterology 2017, 153, 711–722. [Google Scholar] [CrossRef] [PubMed]
  2. Farhangi, M.A.; Dehghan, P.; Musazadeh, V.; Kavyani, M.; Maleki, P. Effectiveness of omega-3 and prebiotics on adiponectin, leptin, liver enzymes lipid profile and anthropometric indices in patients with non-alcoholic fatty liver disease: A randomized controlled trial. J. Funct. Foods 2022, 92, 105074. [Google Scholar] [CrossRef]
  3. Lécuyer, L.; Laouali, N.; Viallon, V.; Artaud, F.; Hébert, J.R.; Shivappa, N.; Agudo, A.; Tjønneland, A.; Mellemkjær, L.; Kaaks, R.; et al. Associations between dietary inflammatory scores and biomarkers of inflammation in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Clin. Nutr. 2023, 42, 1115–1125. [Google Scholar] [CrossRef] [PubMed]
  4. Jamar, G.; Santamarina, A.B.; Casagrande, B.P.; Estadella, D.; de Rosso, V.V.; Wagner, R.; Fagundes, M.B.; Pisani, L.P. Prebiotic potencial of juçara berry on changes in gut bacteria and acetate of individuals with obesity. Eur. J. Nutr. 2020, 59, 3767–3778. [Google Scholar] [CrossRef] [PubMed]
  5. Vaghef-Mehrabany, E.; Ranjbar, F.; Asghari-Jafarabadi, M.; Hosseinpour-Arjmand, S.; Ebrahimi-Mameghani, M. Calorie restriction in combination with prebiotic supplementation in obese women with depression: Effects on metabolic and clinical response. Nutr. Neurosci. 2021, 24, 339–353. [Google Scholar] [PubMed]
  6. Behrouz, V.; Jazayeri, S.; Aryaeian, N.; Zahedi, M.J.; Hosseini, F. Effects of probiotic and prebiotic supplementation on leptin, adiponectin, and glycemic parameters in non-alcoholic fatty liver disease: A randomized clinical trial. Middle East J. Dig. Dis. 2017, 9, 150. [Google Scholar] [CrossRef] [PubMed]
  7. Visuthranukul, C.; Sriswasdi, S.; Tepaamorndech, S.; Chamni, S.; Leelahavanichkul, A.; Joyjinda, Y.; Aksornkitti, V.; Chomtho, S. Enhancing gut microbiota and microbial function with inulin supplementation in children with obesity. Int. J. Obes. 2024, 48, 1696–1704. [Google Scholar] [CrossRef] [PubMed]
  8. Aliasgharzadeh, A.; Khalili, M.; Mirtaheri, E.; Gargari, B.P.; Tavakoli, F.; Farhangi, M.A.; Babaei, A.; Dehghan, P. A combination of prebiotic inulin and oligofructose improve some of cardiovascular disease risk factors in women with type 2 diabetes: A randomized controlled clinical trial. Adv. Pharm. Bull. 2015, 5, 507–514. [Google Scholar] [CrossRef] [PubMed]
  9. Nehmi-Filho, V.; Santamarina, A.B.; de Freitas, J.A.; Trarbach, E.B.; de Oliveira, D.R.; Palace-Berl, F.; de Souza, E.; de Miranda, D.A.; Escamilla-Garcia, A.; Otoch, J.P.; et al. Novel nutraceutical supplements with yeast β-glucan, prebiotics, minerals, and Silybum marianum (silymarin) ameliorate obesity-related metabolic and clinical parameters: A double-blind randomized trial. Front. Endocrinol. 2023, 13, 1089938. [Google Scholar] [CrossRef] [PubMed]
  10. Dewulf, E.M.; Cani, P.D.; Claus, S.P.; Fuentes, S.; Puylaert, P.G.; Neyrinck, A.M.; Bindels, L.B.; de Vos, W.M.; Gibson, G.R.; Thissen, J.-P.; et al. Insight into the prebiotic concept: Lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut 2012, 62, 1112–1121. [Google Scholar] [CrossRef] [PubMed]
  11. Gholizadeh Shamasbi, S.; Dehghan, P.; Mohammad-Alizadeh-Charandabi, S.; Aliasgarzadeh, A.; Mirghafourvand, M. The effect of resistant dextrin as a prebiotic on metabolic parameters and androgen levels in women with polycystic ovarian syndrome: A randomized, triple-blind, controlled clinical trial. Eur. J. Nutr. 2019, 58, 629–640. [Google Scholar] [PubMed]
  12. Dehghan, P.; Gargari, B.P.; Jafar-Abadi, M.A. Oligofructose-enriched inulin improves some inflammatory markers and metabolic endotoxemia in women with type 2 diabetes mellitus: A randomized controlled clinical trial. Nutrition 2014, 30, 418–423. [Google Scholar] [CrossRef] [PubMed]
  13. Edrisi, F.; Salehi, M.; Ahmadi, A.; Fararoei, M.; Rusta, F.; Mahmoodianfard, S. Effects of supplementation with rice husk powder and rice bran on inflammatory factors in overweight and obese adults following an energy-restricted diet: A randomized controlled trial. Eur. J. Nutr. 2018, 57, 833–843. [Google Scholar] [CrossRef] [PubMed]
Table 1. Effects of Prebiotics on Obesity Metrics.
Table 1. Effects of Prebiotics on Obesity Metrics.
SourcePrebioticDosageDurationEffectsReferenceDietPopulation
Chicory rootOligofructose-enriched inulin8 g/day16 weeksSlowed weight gain, reduced body fat, trunk fat[1]Ad libitum42 obese children (Canada, 10–12 years)
Corn-derivedResistant dextrin (NUTRIOSE®06FM)10 g/day12 weeksDecreased weight, BMI, WC, HC, NC[2]Reduced omega-3Iran, adults (BMI 25–35)
Chicory rootNative inulin16 g/day12 weeksImproved psychological parameters[3]HypocaloricBelgium, adults (BMI > 30)
Juçara palmLyophilized juçara5 g/day6 weeksNo significant reduction[4]Ad libitumBrazil, obese adults (BMI 30–40)
Chicory rootInulin10 g/day8 weeksReduced weight, WC, HC, total cholesterol[5]Calorie restrictionIran, obese women (BMI 30–40)
Chicory rootOligofructose-enriched inulin10 g/day8 weeksReduced BMI, WC, HC, diastolic BP[8]Normal dietIran, women (BMI > 25)
Plant-based fibersNutraceutical supplementN/S25 weeksReduced WC[9]No interventionItaly, healthy volunteers (BMI ≤ 34.9)
Jerusalem artichokeOligofructose-enriched inulin13 g/day24 weeksDecreased BMI z-score, FMI, trunk FMI[7]No interventionThailand, obese children (7–15 years)
Chicory rootInulin/oligofructose mix16 g/day12 weeksSlight decrease in fat mass, plasma lactate[10]Weight loss adviceBelgium, obese women (BMI > 30)
Corn-derivedResistant dextrin10 g/day12 weeksReduced anthropometric indices[11]No interventionIran, women with PCOS
Chicory rootOligofructose powder16 g/day12 weeksDecreased leptin, insulin, HOMA-IR[6]No interventionIran, NAFLD patients (BMI 25–40)
Chicory rootInulin10 g/day8 weeksDecreased fasting glucose, energy intake, pro-inflammatory markers[12]No interventionIran, diabetic women (BMI 25–35)
Rice bran/huskRice bran powderN/S12 weeksDecreased weight, BMI, WC, pro-inflammatory markers[13]Energy-restrictedIran, adults (BMI ≥ 25)
N/S = Not specified; WC = Waist circumference; HC = Hip circumference; NC = Neck circumference; BP = Blood pressure; FMI = Fat mass index.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Ghodbane, I.; Boukhechem, S.; Bougherara, H.; Monnoye, M.; Oubira, I.; Lakhdara, N.; Gerard, P.; Dib, A.L. The Role of Plant-Derived Prebiotics in Obesity Management: Mechanisms, Efficacy, and Active Compounds. Biol. Life Sci. Forum 2025, 49, 13. https://doi.org/10.3390/blsf2025049013

AMA Style

Ghodbane I, Boukhechem S, Bougherara H, Monnoye M, Oubira I, Lakhdara N, Gerard P, Dib AL. The Role of Plant-Derived Prebiotics in Obesity Management: Mechanisms, Efficacy, and Active Compounds. Biology and Life Sciences Forum. 2025; 49(1):13. https://doi.org/10.3390/blsf2025049013

Chicago/Turabian Style

Ghodbane, Ilyes, Said Boukhechem, Hithem Bougherara, Magali Monnoye, Ibtissem Oubira, Nedjoua Lakhdara, Philippe Gerard, and Amira Leila Dib. 2025. "The Role of Plant-Derived Prebiotics in Obesity Management: Mechanisms, Efficacy, and Active Compounds" Biology and Life Sciences Forum 49, no. 1: 13. https://doi.org/10.3390/blsf2025049013

APA Style

Ghodbane, I., Boukhechem, S., Bougherara, H., Monnoye, M., Oubira, I., Lakhdara, N., Gerard, P., & Dib, A. L. (2025). The Role of Plant-Derived Prebiotics in Obesity Management: Mechanisms, Efficacy, and Active Compounds. Biology and Life Sciences Forum, 49(1), 13. https://doi.org/10.3390/blsf2025049013

Article Metrics

Back to TopTop